- Exchange: EN Brussels
- Sector: Health Care
- Industry: Biotech & Pharma
- Sub-Industry: Specialty Pharma
TiGenix NV+ Add to Watchlist
TIG:BB0.5350 EUR 0.0050 0.93%
As of 05:44:51 ET on 08/20/2014.
Company Profile for TiGenix NV (TIG)
TiGenix N.V. is a biomedical company focused on cell therapy. The Company researches and develops treatments for autoimmune and inflammatory diseases.
Key Executives for TiGenix NV (TIG)
|Eduardo Bravo Fernandez De AraozCEO/Managing Director||Claudia D AugustaCFO/Secy/Compliance Officer|
|Wilfried DalemansChief Technology Officer||Hans HerklotsDir:Investor & Media Relations|